Korea Investment Partners

Raywatt is a startup focused on developing innovative medical devices for cardiovascular interventions. The company operates a health technology platform that features advanced laser-based imaging technology. This platform includes OCT-based machine learning for fractional flow reserve (FFR) prediction and catheter-based high-speed optical coherence tomography (OCT) imaging. By offering high-speed and high-resolution imaging solutions, Raywatt aims to enhance the capabilities of healthcare professionals in diagnosing and treating cardiovascular diseases.

Raywatt is a startup focused on developing innovative medical devices for cardiovascular interventions. The company operates a health technology platform that features advanced laser-based imaging technology. This platform includes OCT-based machine learning for fractional flow reserve (FFR) prediction and catheter-based high-speed optical coherence tomography (OCT) imaging. By offering high-speed and high-resolution imaging solutions, Raywatt aims to enhance the capabilities of healthcare professionals in diagnosing and treating cardiovascular diseases.

ALDAVER provides incredibly realistic personalized surgical training models using innovative biopolymer materials that closely resemble human tissues and 3D printing technology.

EYEQ Lab is an engineering service company that specializes in the development and manufacturing of power semiconductors. The company aims to revolutionize the power semiconductor industry by applying its expertise and advanced technologies to various sectors. Its products cater to a range of applications, including solar cells, autonomous vehicles, high-speed battery chargers, medical equipment, and aerospace. EYEQ Lab's focus on innovation and skilled engineering enables its customers to stay at the forefront of power semiconductor technologies.

DYNE Medical Group is a medical equipment manufacturer specializing in endoscopy devices and artificial intelligence solutions for urological surgery. The company focuses on developing advanced manufacturing technologies that enhance the capabilities of reusable flexible endoscopes. By employing unique optimization design and ultra-precision processing techniques, DYNE Medical Group aims to improve the effectiveness of endoscopic procedures, facilitating minimally invasive treatment options for patients. Additionally, the company is involved in creating AI-based diagnostic tools for cancer detection, positioning itself at the forefront of technological innovation in the medical field.

Caremedi is a healthcare company focused on developing innovative medical devices, particularly a wearable drug pump designed to enhance the quality of life for individuals with diabetes. The company offers a range of healthcare products, including medical equipment, nebulizers, aspirators, and massagers, allowing consumers to conveniently order these items from home. By prioritizing user-friendly solutions, Caremedi aims to improve the lifestyles of its customers through accessible and effective healthcare technology.

Thorough Future specializes in the integration of advanced technology within the medical sector, focusing on enhancing diagnostic services in clinical medicine. The company leverages artificial intelligence and big data to offer intelligent diagnosis and predictive services for pathology images. This innovative approach aims to improve diagnostic accuracy and efficiency, particularly for cancer patients, by providing personalized treatment recommendations. Through its commitment to integrating cutting-edge technology into healthcare, Thorough Future seeks to transform the way medical diagnoses are conducted and treatments are tailored.

Atoplex is a home test system and diagnosis platform using molecular immunodiagnosis technology.

Dr.Diary is a company that provides a comprehensive diabetes management application aimed at helping users monitor and manage their condition effectively. Founded in 2017 and based in Seoul, South Korea, the application allows users to track their blood glucose levels, exercise routines, and food intake, while offering insights on how these factors influence their health. In addition to these features, the platform includes medicine intake reminders, monthly health reports, and daily tips on diabetes management. It also facilitates communication with friends and provides personal consultation services with healthcare professionals, enhancing the overall user experience in managing diabetes.

GenEdit Inc., founded in 2016 and based in Berkeley, California, focuses on advancing gene therapy through its innovative genome editing tools, particularly the CRISPR/Cas9 system. The company aims to address the challenges associated with gene therapy delivery by utilizing its proprietary NanoGalaxy™ platform, which systematically screens a library of nanoparticles to enhance the safety and efficiency of delivering genetic material to target tissues. GenEdit's technology is designed to facilitate therapeutic gene editing, offering a solution that is easier, faster, and more accurate than traditional methods. This positions GenEdit to potentially enable the treatment of previously incurable genetic diseases, significantly contributing to the future of non-viral, gene editing-based therapeutics.

Sky Labs is focused on developing innovative wearable technology for continuous health monitoring, specifically targeting atrial fibrillation, a common but often undiagnosed heart condition. The company’s flagship product, the Cardio Tracker (CART), is a cuffless, ring-type device that allows users to monitor their heart health effortlessly by simply wearing it on their finger. This device is designed to be comfortable and practical for daily use, being waterproof and dustproof so that it can be worn continuously, even during activities like showering. The CART operates without requiring user intervention, automatically detecting and recording instances of atrial fibrillation to provide users with real-time health data accessible via a smartphone app. This capability not only helps users manage their heart health but also assists healthcare professionals in diagnosing atrial fibrillation based on the data collected. Sky Labs is currently engaged in clinical trials with Seoul National University Hospital to validate the device's performance and is collaborating with Bayer to enhance its healthcare offerings. The initial target market includes atrial fibrillation patients in Finland, with a broader goal of reaching millions globally.

TSD Life Sciences Co., Ltd., established in 2016 and based in Seoul, South Korea, specializes in the research and development of pharmaceuticals aimed at treating rare and intractable diseases, particularly cancer. The company offers a range of clinical research services, including non-clinical and clinical operations, project management, and support for orphan drug designation. TSD Life Sciences focuses on developing antibody drugs that address incurable diseases, thereby empowering healthcare professionals to effectively treat patients with rare conditions.

Infit & Company Inc. is a manufacturer of medical diagnostic devices and wellness devices that targeting global healthcare industry.

Olive Healthcare is a digital healthcare company specializing in medical diagnostic devices with a focus on abdominal fat scanning and breast cancer diagnosis. Utilizing non-radiative and non-invasive near infrared (NIR) technology, along with artificial intelligence algorithms and big data processing, Olive Healthcare offers customized medical services. Their devices are designed to measure abdominal fat status and provide tailored exercise and diet guidance, helping users to reduce belly fat and mitigate the risk of metabolic diseases. Through these innovative approaches, Olive Healthcare aims to enhance patient care and improve health outcomes.

BioPharmX, Inc. provides innovative drug-delivery products through its unique, patented platform technologies for pharmaceutical and OTC applications. Its products are designed to address unmet needs in large, well-defined and under-served markets in the fast growing health and wellness markets, including dermatology, women's health and Ear, Nose and Throat (ENT) therapy. The BioPharmX management team consists of Silicon Valley executives, scientists and business professionals combining large company discipline with deep bio-tech expertise focused on drug delivery and molecular properties. Technical expertise includes pharmaceutical, biological sciences, medical devices and consumer product development with extensive experience in ex vivo/in vitro design, preclinical and clinical development, as well as intellectual property generation. Quality and regulatory expertise includes knowledge of medical directives, US FDA guidance for drugs and medical devices and ICH & IEC guidelines for the US, Canada. China and European Union.